AtaiBeckley (ATAI) EBIT Margin (2021 - 2026)
AtaiBeckley's quarterly EBIT Margin came in at 3239.1% in Q1 2026, down 192913.0% year-on-year from N/an in Q1 2025, and down 147.27% quarter-over-quarter from 1309.97% in Q1 2025.
AtaiBeckley's EBIT Margin history runs 5 years deep, the most recent figure standing at 3796.53% for Q3 2025.
- In Q3 2025, EBIT Margin rose 5270847.0% year-over-year to 3796.53%; the TTM figure through Sep 2025 stood at 3438.02% (up 2857920.0% YoY), while the FY2024 annual figure was 33341.23%, up 661768.0% from the prior year.
- EBIT Margin for Q1 2026 stood at 3239.1%, down from 1309.97% in the prior quarter.
- The five-year high for EBIT Margin was 1309.97% in Q1 2025, with the low at 3239.1% in Q1 2026.
- A 5-year average of 60266.07% and a median of 20219.77% in 2021 frame the typical range for EBIT Margin.
- Across the five-year window, EBIT Margin plunged 14755410 bps in 2022 and jumped 12925216 bps in 2023, its largest moves.
- AtaiBeckley's EBIT Margin stood at 19641.3% in 2021, then slumped by 403 bps to 98855.26% in 2022, then plunged by 89 bps to 186450.0% in 2023, then slumped by 35 bps to 252208.33% in 2024, then jumped by 98 bps to 3796.53% in 2025.
- According to Business Quant data, EBIT Margin over the past three periods registered 3796.53%, 3515.02%, and 1309.97% for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -6.43% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 38.10% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 17.83% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 23.02% |
| 10 | AtaiBeckley | 1.62 Bn | 1.62 Bn | - | -3,239.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,239.10% |
| Sep 30, 2025 | -3,796.53% |
| Jun 30, 2025 | -3,515.02% |
| Mar 31, 2025 | -1,309.97% |
| Mar 31, 2025 | -1,309.97% |
| Dec 31, 2024 | -252,208.33% |
| Sep 30, 2024 | -56,505.00% |
| Jun 30, 2024 | -9,424.54% |
| Dec 31, 2023 | -186,450.00% |
| Sep 30, 2023 | -30,843.68% |
| Jun 30, 2023 | -18,524.42% |
| Mar 31, 2023 | -89,767.57% |
| Dec 31, 2022 | -98,855.26% |
| Sep 30, 2022 | -160,095.83% |
| Jun 30, 2022 | -20,798.24% |
| Dec 31, 2021 | -19,641.30% |
| Sep 30, 2021 | -12,541.73% |
| Mar 31, 2021 | 20.37% |